HomeCompareNWPHF vs FCPT

NWPHF vs FCPT: Dividend Comparison 2026

NWPHF yields 16.67% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NWPHF wins by $10.3K in total portfolio value
10 years
NWPHF
NWPHF
● Live price
16.67%
Share price
$12.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$59.4K
Annual income
$4,638.76
Full NWPHF calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — NWPHF vs FCPT

📍 NWPHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNWPHFFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NWPHF + FCPT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NWPHF pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NWPHF
Annual income on $10K today (after 15% tax)
$1,416.67/yr
After 10yr DRIP, annual income (after tax)
$3,942.95/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, FCPT beats the other by $966.04/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NWPHF + FCPT for your $10,000?

NWPHF: 50%FCPT: 50%
100% FCPT50/50100% NWPHF
Portfolio after 10yr
$54.2K
Annual income
$5,207.02/yr
Blended yield
9.60%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

NWPHF
No analyst data
Altman Z
4.4
Piotroski
5/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NWPHF buys
0
FCPT buys
0
No recent congressional trades found for NWPHF or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNWPHFFCPT
Forward yield16.67%6.05%
Annual dividend / share$2.00$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$59.4K$49.1K
Annual income after 10y$4,638.76$5,775.28
Total dividends collected$30.6K$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: NWPHF vs FCPT ($10,000, DRIP)

YearNWPHF PortfolioNWPHF Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$12,367$1,666.67$11,401$700.92+$966.00NWPHF
2$15,159$1,926.27$13,064$864.84+$2.1KNWPHF
3$18,426$2,206.69$15,051$1,072.48+$3.4KNWPHF
4$22,223$2,506.90$17,442$1,337.22+$4.8KNWPHF
5$26,604$2,825.66$20,340$1,677.08+$6.3KNWPHF
6$31,628$3,161.43$23,880$2,116.57+$7.7KNWPHF
7$37,355$3,512.53$28,241$2,689.36+$9.1KNWPHF
8$43,847$3,877.10$33,660$3,442.07+$10.2KNWPHF
9$51,169$4,253.19$40,456$4,439.95+$10.7KNWPHF
10$59,390$4,638.76$49,063$5,775.28+$10.3KNWPHF

NWPHF vs FCPT: Complete Analysis 2026

NWPHFStock

Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease, as well as develops Xadago for the treatment of levodopa induced dyskinesia. It also develops Evenamide for Schizophrenia and treatment resistant schizophrenia; and Ralfinamide for orphan indication in neuropathic pain. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy.

Full NWPHF Calculator →

FCPTREIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this NWPHF vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NWPHF vs SCHDNWPHF vs JEPINWPHF vs ONWPHF vs KONWPHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.